OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group
Marinde J. G. Bond, Karen Bolhuis, O. J. L. Loosveld, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 7, pp. 757-771
Open Access | Times Cited: 76
Marinde J. G. Bond, Karen Bolhuis, O. J. L. Loosveld, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 7, pp. 757-771
Open Access | Times Cited: 76
Showing 1-25 of 76 citing articles:
Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial
René Adam, Céline Piedvache, L. Chiche, et al.
The Lancet (2024) Vol. 404, Iss. 10458, pp. 1107-1118
Closed Access | Times Cited: 38
René Adam, Céline Piedvache, L. Chiche, et al.
The Lancet (2024) Vol. 404, Iss. 10458, pp. 1107-1118
Closed Access | Times Cited: 38
Development and evaluation of hyaluronic acid-coated chitosan nanoparticles for improved delivery of sorafenib tosylate in the treatment of hepatocellular carcinoma
Putrevu Sreelaya, Sankha Bhattacharya, Darshan Bhirud, et al.
BioNanoScience (2025) Vol. 15, Iss. 1
Closed Access | Times Cited: 2
Putrevu Sreelaya, Sankha Bhattacharya, Darshan Bhirud, et al.
BioNanoScience (2025) Vol. 15, Iss. 1
Closed Access | Times Cited: 2
A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidedness
Takayuki Yoshino, Naushin Hooda, Diana Younan, et al.
European Journal of Cancer (2024) Vol. 202, pp. 113975-113975
Closed Access | Times Cited: 9
Takayuki Yoshino, Naushin Hooda, Diana Younan, et al.
European Journal of Cancer (2024) Vol. 202, pp. 113975-113975
Closed Access | Times Cited: 9
Nucleus-translocated GCLM promotes chemoresistance in colorectal cancer through a moonlighting function
Jin‐Fei Lin, Zexian Liu, Dongliang Chen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Jin‐Fei Lin, Zexian Liu, Dongliang Chen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Management of metastatic colorectal cancer: consensus in the Gulf Cooperation Council countries
Bazarbashi Shouki, Ahmed Abdelsalam, Amirul Al‐Ashraf Abdullah, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access | Times Cited: 1
Bazarbashi Shouki, Ahmed Abdelsalam, Amirul Al‐Ashraf Abdullah, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access | Times Cited: 1
Efficacy of Combined PD-1 Inhibitor and Bevacizumab in Unresectable Liver Metastasis of MSI-H Colorectal Cancer: A Case Report
Qifan Wang, Jie Zhong, Yi Wang, et al.
American Journal of Case Reports (2025) Vol. 26
Closed Access | Times Cited: 1
Qifan Wang, Jie Zhong, Yi Wang, et al.
American Journal of Case Reports (2025) Vol. 26
Closed Access | Times Cited: 1
Cancer treatment monitoring using cell-free DNA fragmentomes
Iris van ’t Erve, Bahar Alipanahi, Keith Lumbard, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Iris van ’t Erve, Bahar Alipanahi, Keith Lumbard, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases
Marinde J. G. Bond, Karen Bolhuis, O. J. L. Loosveld, et al.
JAMA Oncology (2024) Vol. 11, Iss. 1, pp. 36-36
Closed Access | Times Cited: 5
Marinde J. G. Bond, Karen Bolhuis, O. J. L. Loosveld, et al.
JAMA Oncology (2024) Vol. 11, Iss. 1, pp. 36-36
Closed Access | Times Cited: 5
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial
De‐Shen Wang, Chao Ren, Shanshan Li, et al.
PLoS Medicine (2024) Vol. 21, Iss. 5, pp. e1004389-e1004389
Open Access | Times Cited: 4
De‐Shen Wang, Chao Ren, Shanshan Li, et al.
PLoS Medicine (2024) Vol. 21, Iss. 5, pp. e1004389-e1004389
Open Access | Times Cited: 4
Advancements in the Management of Synchronous Colorectal Liver Metastases: A Comprehensive Review of Surgical, Systemic, and Local Treatment Modalities
Beliz Bahar Karaoğlan, Diğdem Kuru Öz, Mine Araz, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 7, pp. 791-803
Open Access | Times Cited: 4
Beliz Bahar Karaoğlan, Diğdem Kuru Öz, Mine Araz, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 7, pp. 791-803
Open Access | Times Cited: 4
First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trial
Zixian Wang, Junjie Peng, Xinjun Liang, et al.
Med (2024) Vol. 5, Iss. 9, pp. 1150-1163.e3
Closed Access | Times Cited: 4
Zixian Wang, Junjie Peng, Xinjun Liang, et al.
Med (2024) Vol. 5, Iss. 9, pp. 1150-1163.e3
Closed Access | Times Cited: 4
CSCO guidelines for colorectal cancer version 2024: Updates and discussions.
Liubo Chen, Hanguang Hu, Ying Yuan, et al.
PubMed (2024) Vol. 36, Iss. 3, pp. 233-239
Closed Access | Times Cited: 4
Liubo Chen, Hanguang Hu, Ying Yuan, et al.
PubMed (2024) Vol. 36, Iss. 3, pp. 233-239
Closed Access | Times Cited: 4
Analysis of the effectiveness and safety of lenvatinib/bevacizumab combined with PD-1/PD-L1 inhibitors and GEMOX in the first-line treatment of advanced biliary tract carcinoma
Lu Zhao, Zhengfeng Zhang, Dazhen Wang, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Lu Zhao, Zhengfeng Zhang, Dazhen Wang, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
EORTC consensus recommendations on the optimal management of colorectal Cancer liver metastases
Giacomo Bregni, Richard Adams, Reto Bale, et al.
Cancer Treatment Reviews (2025), pp. 102926-102926
Closed Access
Giacomo Bregni, Richard Adams, Reto Bale, et al.
Cancer Treatment Reviews (2025), pp. 102926-102926
Closed Access
Molekulare Testung und Liquid Biopsies bei kolorektalen Karzinomen
Arndt Stahler, Sebastian Stintzing
Deleted Journal (2025)
Closed Access
Arndt Stahler, Sebastian Stintzing
Deleted Journal (2025)
Closed Access
A systematic review and network meta-analysis of RCTs: The effect of systemic immunotherapies on treatment outcomes and quality of life in patients with metastatic colorectal cancer
Yiying Zhu, Xiangwei Fu, Yonggang Dai
Advances in Clinical and Experimental Medicine (2025) Vol. 34, Iss. 11
Open Access
Yiying Zhu, Xiangwei Fu, Yonggang Dai
Advances in Clinical and Experimental Medicine (2025) Vol. 34, Iss. 11
Open Access
Resectability assessment of colorectal liver metastases by an expert panel: potential impact on hospitals referring patients for local treatment
Marinde J. G. Bond, Cornelis Verhoef, Geert Kazemier, et al.
European Journal of Surgical Oncology (2025) Vol. 51, Iss. 6, pp. 109681-109681
Closed Access
Marinde J. G. Bond, Cornelis Verhoef, Geert Kazemier, et al.
European Journal of Surgical Oncology (2025) Vol. 51, Iss. 6, pp. 109681-109681
Closed Access
Detection of KRAS Mutations Using Extracellular Vesicle DNA in Colorectal Cancer Patients
Sho Kuriyama, Takeshi Yamada, Toshimitsu Miyasaka, et al.
Cancer Science (2025)
Open Access
Sho Kuriyama, Takeshi Yamada, Toshimitsu Miyasaka, et al.
Cancer Science (2025)
Open Access
FOLFIRI With Cetuximab or Bevacizumab in RAS Wild-type Metastatic Colorectal Cancer: Refining First-line Treatment Selection by Combining Clinical Parameters A Post Hoc Analysis of the Randomized Open-label Phase III trial FIRE-3/AIO KRK0306
Julian Walter Holch, Alexander J. Ohnmacht, Sebastian Stintzing, et al.
European Journal of Cancer (2025), pp. 115388-115388
Open Access
Julian Walter Holch, Alexander J. Ohnmacht, Sebastian Stintzing, et al.
European Journal of Cancer (2025), pp. 115388-115388
Open Access
Optimization of Therapy: Drug Development, Pharmacokinetics, and Pharmacodynamics
Fidel David Huitzil Melendez, Mónica Isabel Meneses Medina, Emilio Conde-Flores, et al.
(2025), pp. 31-53
Closed Access
Fidel David Huitzil Melendez, Mónica Isabel Meneses Medina, Emilio Conde-Flores, et al.
(2025), pp. 31-53
Closed Access
Overall Survival in the CAIRO5 Clinical Trial—Reply
Marinde J. G. Bond, Rutger‐Jan Swijnenburg, Cornelis J. A. Punt
JAMA Oncology (2025)
Closed Access
Marinde J. G. Bond, Rutger‐Jan Swijnenburg, Cornelis J. A. Punt
JAMA Oncology (2025)
Closed Access
Long-Term Outcomes of Patients Undergoing Conversion Surgery After Induction Chemotherapy: Turkish Oncology Group Study
Furkan Ceylan, Seli̇n Aktürk Esen, Olçun Ümit Ünal, et al.
Medicina (2025) Vol. 61, Iss. 5, pp. 776-776
Open Access
Furkan Ceylan, Seli̇n Aktürk Esen, Olçun Ümit Ünal, et al.
Medicina (2025) Vol. 61, Iss. 5, pp. 776-776
Open Access
Overview of the Surgical Management of Liver Oligometastatic Disease in Colorectal Cancer
Anca Monica Oprescu Macovei, Dana Paula Venter, Bogdan Dumitriu, et al.
Journal of Mind and Medical Sciences (2025) Vol. 12, Iss. 1, pp. 31-31
Open Access
Anca Monica Oprescu Macovei, Dana Paula Venter, Bogdan Dumitriu, et al.
Journal of Mind and Medical Sciences (2025) Vol. 12, Iss. 1, pp. 31-31
Open Access
Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer
Yoshihito Kano, Mitsukuni Suenaga, Hiroyuki Uetake
Current Oncology (2023) Vol. 30, Iss. 7, pp. 6546-6558
Open Access | Times Cited: 9
Yoshihito Kano, Mitsukuni Suenaga, Hiroyuki Uetake
Current Oncology (2023) Vol. 30, Iss. 7, pp. 6546-6558
Open Access | Times Cited: 9
Combined Hepatic Arterial Infusion Pump and Systemic Chemotherapy in the Modern Era for Chemotherapy-Naive Patients with Unresectable Colorectal Liver Metastases
Floris S. Verheij, Koert F.D. Kuhlmann, Danielle R. Silliman, et al.
Annals of Surgical Oncology (2023) Vol. 30, Iss. 13, pp. 7950-7959
Closed Access | Times Cited: 7
Floris S. Verheij, Koert F.D. Kuhlmann, Danielle R. Silliman, et al.
Annals of Surgical Oncology (2023) Vol. 30, Iss. 13, pp. 7950-7959
Closed Access | Times Cited: 7
